Effects of pregabalin on smoking behavior, withdrawal symptoms, and cognitive performance in smokers

Psychopharmacology

Volumn 220, Issue 3, 2012, Pages 611-617

  Herman, Aryeh I ^a   Waters, Andrew J ^b   McKee, Sherry A ^a   Sofuoglu, Mehmet ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Attentional bias; Cigarette smoking; GABA; Nicotine; Pregabalin

Indexed keywords

PLACEBO; PREGABALIN;

ADULT; ANXIETY; ARTICLE; ATTENTION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG HALF LIFE; DRUG WITHDRAWAL; FEMALE; FRUSTRATION; HUMAN; IRRITABILITY; MALE; MENTAL TASK; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; SMOKING CESSATION; SMOKING HABIT; TASK PERFORMANCE; VERTIGO; WITHDRAWAL SYNDROME;

ADULT; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; NICOTINE; OUTPATIENTS; PSYCHOMOTOR PERFORMANCE; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER; YOUNG ADULT;

EID: 84857821729     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2507-x     Document Type: Article

References (50)

1. Bell SL, Taylor RC, Singleton EG, Henningfield JE, Heishman SJ (1999) Smoking after nicotine deprivation enhances cognitive performance and decreases tobacco craving in drug abusers. Nicotine Tob Res 1:45-52, in process citation
2. Ben-Menachem E (2004) Pregabalin pharmacology and its relevance to clinical practice. Epilepsia 45(Suppl 6):13-18 (Pubitemid 39350325)
3. Benowitz NL, Zevin S, Jacob P 3rd (1998) Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine. J Pharmacol Exp Ther 287:958-962 (Pubitemid 29131607)
4. Bisaga A, Padilla M, Garawi F, Sullivan MA, Haney M (2007) Effects of alternative reinforcer and craving on the choice to smoke cigarettes in the laboratory. Hum Psychopharmacol 22:41-47 (Pubitemid 46178777)
5. Bockbrader HN, Wesche D, Miller R, Chapel S, Janiczek N, Burger P (2010) A comparison of the pharmacokinetics and pharmacody-namics of pregabalin and gabapentin. Clin Pharmacokinet 49:661-669
6. Brandon TH, Tiffany ST, Obremski KM, Baker TB (1990) Postcessation cigarette use: the process of relapse. Addict Behav 15:105-114 (Pubitemid 20155202)
7. Buchhalter AR, Acosta MC, Evans SE, Breland AB, Eissenberg T (2005) Tobacco abstinence symptom suppression: the role played by the smoking-related stimuli that are delivered by denicotinized cigarettes. Addiction 100:550-559 (Pubitemid 40529848)
8. Cousins MS, Stamat HM, de Wit H (2001) Effects of a single dose of baclofen on self-reported subjective effects and tobacco smoking. Nicotine Tob Res 3:123-129 (Pubitemid 32621773)
9. Cox LS, Tiffany ST, Christen AG (2001) Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob Res 3:7-16 (Pubitemid 32611534)
10. Delahoy P, Thompson S, Marschner IC (2010) Pregabalin versus gabapentin in partial epilepsy: a meta-analysis of dose-response relationships. BMC Neurol 10:104
11. Dewey SL, Brodie JD, Gerasimov M, Horan B, Gardner EL, Ashby CR Jr (1999) A pharmacologic strategy for the treatment of nicotine addiction. Synapse 31:76-86 (Pubitemid 29009282)
12. Di Nicola M, Martinotti G, Tedeschi D, Frustaci A, Mazza M, Sarchiapone M, Pozzi G, Bria P, Janiri L (2010) Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome. Hum Psychopharmacol 25:268-275
13. Errante LD, Williamson A, Spencer DD, Petroff OA (2002) Gabapentin and vigabatrin increase GABA in the human neocortical slice. Epilepsy Res 49:203-210 (Pubitemid 34655561)
14. Fattore L, Cossu G, Martellotta MC, Fratta W (2002) Baclofen antagonizes intravenous self-administration of nicotine in mice and rats. Alcohol Alcohol 37:495-498
15. Feltner D, Wittchen HU, Kavoussi R, Brock J, Baldinetti F, Pande AC (2008) Long-term efficacy of pregabalin in generalized anxiety disorder. Int Clin Psychopharmacol 23:18-28 (Pubitemid 350294866)
16. Fiore MC, Jaen CR, Baker TB (2008) Treating tobacco use and dependence: 2008 update. Clinical practice guideline. US Department of Health and Human Services, Rockville
17. Franklin TR, Harper D, Kampman K, Kildea-McCrea S, Jens W, Lynch KG, O'Brien CP, Childress AR (2009) The GABA B agonist baclofen reduces cigarette consumption in a preliminary double-blind placebo-controlled smoking reduction study. Drug Alcohol Depend 103:30-36
18. French JA, Kugler AR, Robbins JL, Knapp LE, Garofalo EA (2003) Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures. Neurology 60:1631-1637 (Pubitemid 36618090)
19. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO (1991) The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addictions 86:1119-1127
20. Herman AI, Sofuoglu M (2010) Comparison of available treatments for tobacco addiction. Curr Psychiatry Rep 12:433-440
21. Hindmarch I, Trick L, Ridout F (2005) A double-blind, placebo- and positive-internal-controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers. Psychopharmacology (Berl) 183:133-143 (Pubitemid 41609265)
22. Hughes JR, Hatsukami D (1986) Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43:289-294 (Pubitemid 16052281)
23. Hughes JR, Hatsukami DK (1997) Effects of three doses of transdermal nicotine on post-cessation eating, hunger and weight. J Subst Abuse 9:151-159 (Pubitemid 29381592)
24. Kenford SL, Fiore MC, Jorenby DE, Smith SS, Wetter D, Baker TB (1994) Predicting smoking cessation. Who will quit with and without the nicotine patch. JAMA 271:589-594 (Pubitemid 24061691)
25. Madden GJ, Bickel WK (1999) Abstinence and price effects on demand for cigarettes: a behavioral-economic analysis. Addiction 94:577-588 (Pubitemid 29179128)
26. Mansvelder HD, Keath JR, McGehee DS (2002) Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 33:905-919 (Pubitemid 34246356)
27. Martinotti G, di Nicola M, Frustaci A, Romanelli R, Tedeschi D, Guglielmo R, Guerriero L, Bruschi A, De Filippis R, Pozzi G, Di Giannantonio M, Bria P, Janiri L (2010) Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial. Addiction 105:288-99
28. McNair D, Lorr M, Dropperman L (1971) Manual for profile of mood states. Educational and Industrial Testing Services, San Diego
29. Montgomery SA, Tobias K, Zornberg GL, Kasper S, Pande AC (2006) Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine. J Clin Psychiatry 67:771-782 (Pubitemid 43946184)
30. Montgomery S, Chatamra K, Pauer L, Whalen E, Baldinetti F (2008) Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder. Br J Psychiatry 193:389-394
31. Morgan MJ, Davies GM, Willner P (1999) The Questionnaire of Smoking Urges is sensitive to abstinence and exposure to smoking-related cues. Behav Pharmacol 10:619-626 (Pubitemid 30026056)
32. Olmstead TA, Sindelar JL, Easton CJ, Carroll KM (2007) The cost-effectiveness of four treatments for marijuana dependence. Addiction 102:1443-1453 (Pubitemid 47246986)
33. Paterson NE, Markou A (2002) Increased GABA neurotransmission via administration of gamma-vinyl GABA decreased nicotine self-administration in the rat. Synapse 44:252-253 (Pubitemid 34496649)
34. Paterson NE, Froestl W, Markou A (2004) The GABAB receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat. Psychopharmacology 172:179-186 (Pubitemid 38388767)
35. Robertson IH, Manly T, Andrade J, Baddeley BT, Yiend J (1997) 'Oops!': performance correlates of everyday attentional failures in traumatic brain injured and normal subjects. Neuropsychologia 35:747-758 (Pubitemid 27263222)
36. Rohsenow DJ, Tidey JW, Miranda R, McGeary JE, Swift RM, Hutchison KE, Sirota AD, Monti PM (2008) Olanzapine reduces urge to smoke and nicotine withdrawal symptoms in community smokers. Exp Clin Psychopharmacol 16:215-222 (Pubitemid 351822565)
37. SAS Institute Inc. (2007) The SAS System for Windows. SAS Institute Inc., Cary
38. Sayette MA, Hufford MR (1994) Effects of cue exposure and deprivation on cognitive resources in smokers. J Abnorm Psychol 103:812-818 (Pubitemid 24349365)
39. Schwan S, Sundstrom A, Stjernberg E, Hallberg E, Hallberg P (2010) A signal for an abuse liability for pregabalin-results from the Swedish spontaneous adverse drug reaction reporting system. Eur J Clin Pharmacol 66:947-953
40. Shiffman S, Kirchner TR (2009) Cigarette-by-cigarette satisfaction during ad libitum smoking. J Abnorm Psychol 118:348-359
41. Sofuoglu M, Mouratidis M, Yoo S, Culligan K, Kosten T (2005) Effects of tiagabine in combination with intravenous nicotine in overnight abstinent smokers. Psychopharmacology (Berl) 181 (3):504-510 (Pubitemid 41480899)
42. Sofuoglu M, Waters AJ, Mooney M, Kosten T (2008) Riluzole and D-amphetamine interactions in humans. Prog Neuropsychopharma-col Biol Psychiatry 32:16-22
43. Sood A, Ebbert JO, Wyatt KD, Croghan IT, Schroeder DR, Sood R, Hays JT (2010) Gabapentin for smoking cessation. Nicotine Tob Res 12:300-304
44. Soria R, Stapleton JM, Gilson SF, Sampson-Cone A, Henningfield JE, London ED (1996) Subjective and cardiovascular effects of intravenous nicotine in smokers and non-smokers. Psychophar-macology 128:221-226 (Pubitemid 26403117)
45. Strong DR, Leventhal AM, Evatt DP, Haber S, Greenberg BD, Abrams D, Niaura R (2011) Positive reactions to tobacco predict relapse after cessation. J Abnorm Psychol. doi:10.1037/a0023666
46. Stroop JR (1935) Studies of interference in serial verbal reactions. J Exp Psychol 18:643-662
47. Tiffany ST, Drobes DJ (1991) The development and initial validation of a questionnaire on smoking urges. Br J Addict 86:1467-1476
48. Tzellos TG, Toulis KA, Goulis DG, Papazisis G, Zampeli VA, Vakfari A, Kouvelas D (2010) Gabapentin and pregabalin in the treatment of fibromyalgia: a systematic review and a meta-analysis. J Clin Pharm Ther 35:639-656
49. Urban MO, Ren K, Park KT, Campbell B, Anker N, Stearns B, Aiyar J, Belley M, Cohen C, Bristow L (2005) Comparison of the antinociceptive profiles of gabapentin and 3-methylgabapentin in rat models of acute and persistent pain: implications for mechanism of action. J Pharmacol Exp Ther 313:1209-1216 (Pubitemid 40727024)
50. Wade JF, Dang CV, Nelson L, Wasserberger J (2010) Emergent complications of the newer anticonvulsants. J Emerg Med 38:231-237